Growth Metrics

Edwards Lifesciences (EW) Long-Term Investments (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Long-Term Investments data on record, last reported at $274.7 million in Q3 2025.

  • For Q3 2025, Long-Term Investments fell 14.05% year-over-year to $274.7 million; the TTM value through Sep 2025 reached $274.7 million, down 14.05%, while the annual FY2024 figure was $307.9 million, 47.27% down from the prior year.
  • Long-Term Investments reached $274.7 million in Q3 2025 per EW's latest filing, down from $298.5 million in the prior quarter.
  • Across five years, Long-Term Investments topped out at $1.8 billion in Q4 2021 and bottomed at $274.7 million in Q3 2025.
  • Average Long-Term Investments over 5 years is $850.8 million, with a median of $802.2 million recorded in 2021.
  • Peak YoY movement for Long-Term Investments: surged 128.82% in 2021, then tumbled 58.74% in 2024.
  • A 5-year view of Long-Term Investments shows it stood at $1.8 billion in 2021, then tumbled by 32.45% to $1.2 billion in 2022, then tumbled by 52.87% to $583.9 million in 2023, then plummeted by 47.27% to $307.9 million in 2024, then dropped by 10.78% to $274.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $274.7 million in Q3 2025, $298.5 million in Q2 2025, and $277.9 million in Q1 2025.